Universal hepatitis B screening and management in patients with cancer who received immunosuppressive chemotherapy.
Lisa A ThompsonLauren J HeathHeather FremlThomas DelatePublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)
Universal hepatitis B virus screening coupled with a risk-stratified management strategy utilizing HBVr monitoring and anti-hepatitis B virus prophylaxis in HBV+ patients receiving immunosuppressive chemotherapy for cancer may prevent HBVr.